Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lack of mitochondrial toxicity of darunavir, raltegravir and rilpivirine in neurons and hepatocytes: a comparison with efavirenz
Authors
Keywords
-
Journal
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 69, Issue 11, Pages 2995-3000
Publisher
Oxford University Press (OUP)
Online
2014-07-11
DOI
10.1093/jac/dku262
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neuronal Bioenergetics and Acute Mitochondrial Dysfunction: A Clue to Understanding the Central Nervous System Side Effects of Efavirenz
- (2014) Haryes A. Funes et al. JOURNAL OF INFECTIOUS DISEASES
- Rilpivirine Versus Efavirenz in HIV-1–Infected Subjects Receiving Emtricitabine/Tenofovir DF: Pooled 96-Week Data from ECHO and THRIVE Studies
- (2013) M.R. Nelson et al. HIV CLINICAL TRIALS
- Neurological and psychiatric tolerability of rilpivirine (TMC278)vs.efavirenz in treatment-naïve, HIV-1-infected patients at 48 weeks
- (2013) AM Mills et al. HIV MEDICINE
- Durable Efficacy and Safety of Raltegravir Versus Efavirenz When Combined With Tenofovir/Emtricitabine in Treatment-Naive HIV-1–Infected Patients
- (2013) Jürgen K. Rockstroh et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- ER stress in human hepatic cells treated with Efavirenz: Mitochondria again
- (2013) Nadezda Apostolova et al. JOURNAL OF HEPATOLOGY
- HIV-AIDS: much accomplished, much to do
- (2013) Anthony S Fauci et al. NATURE IMMUNOLOGY
- Twenty Years of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: Time to Reevaluate their Toxicity
- (2012) A. Blas-Garcia et al. CURRENT MEDICINAL CHEMISTRY
- Antiretroviral neurotoxicity
- (2012) Kevin Robertson et al. JOURNAL OF NEUROVIROLOGY
- 96 Week Follow-Up of HIV-Infected Patients in Rescue with Raltegravir Plus Optimized Backbone Regimens: A Multicentre Italian Experience
- (2012) Amedeo Capetti et al. PLoS One
- Liver Toxicity of Antiretroviral Drugs
- (2012) Michelle Jones et al. SEMINARS IN LIVER DISEASE
- Compromising mitochondrial function with the antiretroviral drug efavirenz induces cell survival-promoting autophagy
- (2011) Nadezda Apostolova et al. HEPATOLOGY
- Efavirenz and 8-hydroxyefavirenz induce cell death via a JNK- and BimEL-dependent mechanism in primary human hepatocytes
- (2011) Namandjé N. Bumpus TOXICOLOGY AND APPLIED PHARMACOLOGY
- Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-γ inhibition
- (2011) Nadezda Apostolova et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Enhanced oxidative stress and increased mitochondrial mass during Efavirenz-induced apoptosis in human hepatic cells
- (2010) N Apostolova et al. BRITISH JOURNAL OF PHARMACOLOGY
- Inhibition of mitochondrial function by efavirenz increases lipid content in hepatic cells
- (2010) Ana Blas-García et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started